CRVL

CorVel Corporation

CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.

CorVel Corporation (CRVL) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Financial Services sector peers. Its strongest pillar is Momentum (A-); its weakest is Value (C-). The rating has held at C+ for 10 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.8 / 5.0
C+
Value
C-
Factor Score 1.9 / 5.0
Growth
C+
Factor Score 2.7 / 5.0
Profitability
B-
Factor Score 3.0 / 5.0
Momentum
A-
Factor Score 4.1 / 5.0
Revisions
C+
Factor Score 2.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 35.1
EV / EBITDA 20.3
Rev Growth YoY 11.5%
Gross Margin 25.5%
Price Return 3M 33.3%
Price Return 12M 10.1%
Catalyst Signal 0.00
Market Cap $4.2B
TTM Revenue $1.0B
Price / Sales 4.2
ROE 30.6%

Historical Factor Score Progression

Held C+ for 10 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-11 C- (1.9) C+ (2.7) B- (3.0) A- (4.1) C+ (2.5) C+ (2.8)
2026-11-04 C- (1.9) C+ (2.5) B- (3.0) A- (4.1) C+ (2.5) C+ (2.8)
2026-10-28 C- (1.9) C+ (2.5) B- (3.0) A- (3.9) C+ (2.5) C+ (2.8)
2026-10-21 C- (2.0) C (2.5) B- (3.0) A- (3.9) C+ (2.5) C+ (2.8)
2026-10-14 C- (2.0) C (2.4) B- (3.0) A- (3.9) C+ (2.5) C+ (2.8)
Page 1 of 8
…